Evidence map›Paper›PMID 25790174›Full record

ArticleNano letters2015

Nanotopography facilitates in vivo transdermal delivery of high molecular weight therapeutics through an integrin-dependent mechanism.

Laura Walsh, Jubin Ryu, Suzanne Bock, Michael Koval, Theodora Mauro, Russell Ross, Tejal Desai

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Nano letters, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03229798 (An Open-Label Phase 1 Study to Establish the Pharmacokinetics and Safety of Sumatriptan Succinate Administered Via the Sofusa™ DoseConnect™ System at Escalating Doses Compared to Oral Imitrex® Single 100 mg Dose in Healthy Subjects), which is not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03229798 phase1completednot on this mapstarted 2018, after this paper: background citation

An Open-Label Phase 1 Study to Establish the Pharmacokinetics and Safety of Sumatriptan Succinate Administered Via the Sofusa™ DoseConnect™ System at Escalating Doses Compared to Oral Imitrex® Single 100 mg Dose in Healthy Subjects

TypeinterventionalSponsorSorrento Therapeutics, Inc.Ran2018 to 2018Enrolled19ConditionsMigraine DisordersArmsSumatriptan Succinate Oral Tablet, Transdermal delivery of sumatriptan succinate
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Mechanosensory entities and functionality of endothelial cells.Frontiers in cell and developmental biology · 2024
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Above the Matrix: Functional Roles for Apically Localized Integrins.Frontiers in cell and developmental biology · 2021
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Biomaterial-tight junction interaction and potential impacts.Journal of materials chemistry. B · 2019
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Laura Walsh†Department of Bioengineering and Therapeutic Sciences, University of California-San Francisco, 1700 Fourth Street, Room 204, San Francisco, California 94158-2330, United States.
Jubin Ryu‡Department of Dermatology, University of California-San Francisco, 1701 Divisadero Street, San Francisco, California 94115, United States.
Suzanne Bock§Institute for Electronics and Nanotechnology, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Michael Koval∥Division of Pulmonary, Allergy, and Critical Care Medicine and Department of Cell Biology, Emory University School of Medicine, 615 Michael Street, Suite 205, Atlanta, Georgia 30322, United States.
Theodora Mauro‡Department of Dermatology, University of California-San Francisco, 1701 Divisadero Street, San Francisco, California 94115, United States.
Russell Ross#Kimberly-Clark Corporation, 8601 Dunwoody Place, Suite 580, Atlanta, Georgia 30350, United States.
Tejal Desai†Department of Bioengineering and Therapeutic Sciences, University of California-San Francisco, 1700 Fourth Street, Room 204, San Francisco, California 94158-2330, United States.
University of California, San Francisco · USEmory University · USGeorgia Institute of Technology · USKimberly-Clark (United States) · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007618 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S · 1985 to 2020
$29.6M
ATP2A2-Regulated Keretinocyted Ca2+ Signaling MechanismsR01AR051930 · NIAMS · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI MAURO, THEODORA M · 2006 to 2019
$3.2M
Mechanisms of nanostructure-enhanced transepithelial drug deliveryR01EB018842 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DESAI, TEJAL A. · 2014 to 2017
$1.4M
NIAMS NIH HHS R01 AR051930NIBIB NIH HHS R01 EB018842NIBIB NIH HHS R01-EB018842NIGMS NIH HHS T32 GM007618
6 · The paper itself

Abstract

Transdermal delivery of therapeutics is restricted by narrow limitations on size and hydrophobicity. Nanotopography has been shown to significantly enhance high molecular weight paracellular transport in vitro. Herein, we demonstrate for the first time that nanotopography applied to microneedles significantly enhances transdermal delivery of etanercept, a 150 kD therapeutic, in both rats and rabbits. We further show that this effect is mediated by remodeling of the tight junction proteins initiated via integrin binding to the nanotopography, followed by phosphorylation of myosin light chain (MLC) and activation of the actomyosin complex, which in turn increase paracellular permeability.

Indexed as

NeedlesAdministration, CutaneousCaco-2 CellsEquipment DesignEquipment Failure AnalysisEtanerceptHumansIntegrinsMaterials TestingMicroinjectionsMolecular WeightNanotechnologySkin AbsorptionSurface PropertiesEtanerceptIntegrinsdrug deliveryetanerceptintegrinNanotopographytransdermal

Identifiers

PMID25790174
PMCPMC4478088
OpenAlexW2028056617

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.